Bio Spectrum - January 2018
Get Bio Spectrum along with 5,000+ other magazines & newspapers
Try FREE for 7 days
Latest and past issues of 5,000+ magazines & newspapers
Digital Access. Cancel Anytime.1 Year$99.99 $49.99 Save 50%
Latest and past issues of 5,000+ magazines & newspapersDigital Access. Cancel Anytime.Get Bio Spectrum
1 Year $10.99
Save 7%12 issues starting from August 2021 Digital Access. Cancel Anytime.Buy this issue $0.99
January 2018 issue Digital Access. - Magazine Details
- In this issue
Magazine Description
In this issue
Growing Healthcare sector offers huge investment opportunities Indian Healthcare sector is at crossroads. Challenges are many, ranging from rising dual disease burden –both Communicable Disease (CD) and Non-Communicable Disease (NCD) burden, quality, access, affordability, health infrastructure, financing, rational pricing of essential devices, trust deficit between stakeholders, lack of clear policies and regulatory framework. The growing ageing population and rise in cost of their healthcare needs are exerting considerable demands on the health systems. The year 2018 would offer new opportunities for innovators and start-ups in the healthcare sector.
Cancel Anytime [ No Commitments ]
Digital Only
Stride Ventures leads Rs 25 Cr debt round in MediBuddy
Stride Ventures, one of India’s leading venture debt funds, has led a debt round of Rs 25 crore in Bengaluru-based startup MediBuddy that helps its users consult specialist doctors, order medicines and book lab tests from the comfort of their homes.
‘‘We see growing interest of healthcare testing labs, Pharmaceutical QC and R&D labs in implementing next-gen lab automation solutions''
US-based Abbott Informatics, formerly known as STARLIMS, is one of the companies with a long and established presence in the space of lab automation. Taking pride in offering the world class technological solutions, the company has recently announced the launch of STARLIMS Quality Manufacturing Solution QM12.2 which is built on the latest STARLIMS Technology V12 platform, along with STARLIMS SDMS (Scientific Data Management System) V12.2. To find out more about the company’s automated offerings in India, BioSpectrum spoke to Pradeep Nagisetty, Regional Sales Manager - India & Sub Continent, Abbott Informatics - STARLIMS, Hyderabad.
‘Juvenile Idiopathic Arthritis' remains a puzzle
LET'S TALK HEALTH & SCIENCE
India proposes BRICS Consortium to tackle NCDs as flagship programme
Experts deliberated on emerging issues in the various fields of Biotechnology and Biomedicine at the fourth BRICS Working Group meeting on the subject area.
LAB AUTOMATION - TRAVAILS IN INDIA
Whether it is the industry or academia, life sciences workers are gradually accepting the fact that lab data digitisation improves processes, simplifies workflows and makes research and development (R&D) more efficient. With increasing advances in machine learning (ML) and artificial intelligence (AI), digitisation in the research environment is set to become an integral part of every laboratory worldwide. But in emerging markets such as India, there are a large number of factors responsible for its slow adoption such as lack of skilled workforce, high maintenance and service costs, limited expertise, data security etc.
Govt pays Biological E Rs 1500 Cr for 30 Cr vaccines
Union Ministry of Health has finalised arrangements with Hyderabad-based vaccine manufacturer Biological E to reserve 30 crores of COVID-19 vaccine doses.
Biological E, Canadian firm to jointly manufacture mRNA vaccines in India
Canadian firm Providence Therapeutics Holdings Inc. and Hyderabad-based Biological E have announced the execution of a term sheet that sets forth the material terms for a definitive licensing and collaboration agreement.
BDR Pharma launches affordable drug to treat ovarian, prostate cancers
Mumbai-based BDR Pharmaceutical has launched BDPARIB (RUCAPARIB) to treat advanced ovarian and prostate cancers
Zydus Introduces New Feature In Drug Packaging To Avoid Counterfeiting
Zydus Cadila has introduced a new feature called Zydus Verify in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited.
Pandemic Sets New Benchmarks For Early-Stage Healthcare Startups
The COVID-19 pandemic has been an enabler of this change as care-delivery models had to be quickly revamped to address two concerns – the diseases and the impacts of the virus on the treatment of other diseases. We aim to assess the qualitative and quantitative impact of COVID-19 and other macroeconomic events on the startup ecosystem over the last few years and try to understand the implications for the future.
